Date | Time | Source | Announcement |
---|---|---|---|
02 Feb 2006 | 11:00 AM | Final Results - Part 3 of 3 | |
02 Feb 2006 | 11:00 AM | Final Results - Part 2 of 3 | |
02 Feb 2006 | 11:00 AM | Final Results - Part 1 of 3 | |
01 Feb 2006 | 09:00 AM | Notice of Results | |
24 Jan 2006 | 04:00 PM | Director/PDMR Shareholding | |
18 Jan 2006 | 08:24 AM | Toprol-XL | |
03 Jan 2006 | 07:06 AM | Seroquel | |
28 Dec 2005 | 07:00 AM | Collaboration Agreement | |
23 Dec 2005 | 07:00 AM | KuDOS Pharmaceuticals | |
22 Dec 2005 | 02:40 PM | Collaboration | |
20 Dec 2005 | 04:00 PM | Holding(s) in Company | |
16 Dec 2005 | 07:00 AM | Transaction in Own Shares | |
15 Dec 2005 | 12:00 PM | Director/PDMR Shareholding | |
15 Dec 2005 | 07:00 AM | Transaction in Own Shares | |
14 Dec 2005 | 07:00 AM | Transaction in Own Shares | |
09 Dec 2005 | 07:00 AM | Transaction in Own Shares | |
08 Dec 2005 | 07:01 AM | Licensing Agreement | |
08 Dec 2005 | 07:00 AM | Transaction in Own Shares | |
07 Dec 2005 | 07:00 AM | Transaction in Own Shares | |
02 Dec 2005 | 04:00 PM | Director/PDMR Shareholding | |
02 Dec 2005 | 07:00 AM | Transaction in Own Shares | |
01 Dec 2005 | 07:00 AM | Transaction in Own Shares | |
30 Nov 2005 | 04:00 PM | Holding(s) in Company | |
29 Nov 2005 | 07:00 AM | Transaction in Own Shares | |
24 Nov 2005 | 04:00 PM | Holding(s) in Company | |
24 Nov 2005 | 07:00 AM | Transaction in Own Shares | |
23 Nov 2005 | 04:00 PM | Holding(s) in Company | |
22 Nov 2005 | 07:01 AM | Nexium | |
22 Nov 2005 | 07:00 AM | Transaction in Own Shares | |
21 Nov 2005 | 07:00 AM | Transaction in Own Shares | |
18 Nov 2005 | 07:00 AM | Transaction in Own Shares | |
17 Nov 2005 | 04:00 PM | Holding(s) in Company | |
17 Nov 2005 | 07:00 AM | Transaction in Own Shares | |
16 Nov 2005 | 07:00 AM | Transaction in Own Shares | |
15 Nov 2005 | 07:00 AM | Transaction in Own Shares | |
14 Nov 2005 | 07:00 AM | Transaction in Own Shares | |
11 Nov 2005 | 07:00 AM | Transaction in Own Shares | |
10 Nov 2005 | 07:00 AM | Transaction in Own Shares | |
09 Nov 2005 | 07:00 AM | Seroquel | |
07 Nov 2005 | 07:00 AM | Transaction in Own Shares | |
04 Nov 2005 | 07:00 AM | Transaction in Own Shares | |
03 Nov 2005 | 07:00 AM | Transaction in Own Shares | |
01 Nov 2005 | 04:30 PM | Holding(s) in Company | |
31 Oct 2005 | 01:30 PM | Zactima | |
31 Oct 2005 | 07:00 AM | Transaction in Own Shares | |
28 Oct 2005 | 04:00 PM | Holding(s) in Company | |
27 Oct 2005 | 11:00 AM | 3rd Quarter Results (2 of 2) | |
27 Oct 2005 | 11:00 AM | 3rd Quarter Results (1 of 2) | |
26 Oct 2005 | 09:00 AM | Notice of Results | |
21 Oct 2005 | 07:00 AM | Seroquel |
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.
It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.
Astra Zeneca share price launched at 605p in 1993.